Interleukin-1 inhibitors for chronic gout

To assess the efficacy and safety of interleukin-1 inhibitors (anakinra, canakinumab, rilonacept) in chronic gout.

This is a protocol.

Health topics:

Published:

11 July 2012

Authors:

Sivera F, Wechalekar MD, Andrés M, Buchbinder R, Carmona L

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Sivera F, Wechalekar MD, Andrés M, Buchbinder R, Carmona L. Interleukin-1 inhibitors for chronic gout. Cochrane Database of Systematic Reviews 2012, Issue 7. Art. No.: CD009994. DOI: 10.1002/14651858.CD009994